Company intelligence / Profile preview

Composite Interceptive Med-Science Laboratories

Bengaluru Urban, Karnataka, Indiacimedlife.com ↗
Ownership
Private
Employees
~6
Development stage
Other
01

Overview

Composite Interceptive Med‑Science Laboratories appears to be a small, active Indian private company in the biotechnology and healthcare sector. There are no publicly available details on its clinical programs, therapeutic focus, or technology platforms as of June 2025.

Industry
Biotech
02

Drug pipeline

2 assets

Livitol-70

Preclinical

1 more asset in the full pipeline.

Beyond the preview

Go deeper on Composite Interceptive Med-Science Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Composite Interceptive Med-Science Laboratories.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call